
iPS PORTAL
A company focused on stem cell research including iPS cells and regenerative medicine research.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor investor investor investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
$15.1m | Late VC | ||
Total Funding | 000k |
Related Content
iPS Portal is a specialized company offering professional outsourcing services in research and development (R&D), with a strong focus on regenerative medicine, technology, and education. The company serves a diverse range of clients including academic institutions, biotech firms, and pharmaceutical companies. Operating in the highly specialized market of regenerative medicine and advanced technology, iPS Portal provides tailored R&D solutions that help clients accelerate their research and development processes. The business model is service-based, generating revenue through contracts and partnerships for outsourced R&D projects. By leveraging cutting-edge technology and scientific expertise, iPS Portal enables its clients to achieve breakthroughs in medical and technological advancements.
Keywords: R&D outsourcing, regenerative medicine, biotechnology, pharmaceutical, academic research, technology solutions, scientific expertise, advanced technology, medical advancements, tailored solutions.
Investments by iPS PORTAL
Edit